Introduce New Tech Therap in Subcu, Perc, New Tech 5

This code describes the percutaneous injection of a novel therapeutic substance into the subcutaneous tissue. This substance is classified as a "New Technology Therapeutic Substance" belonging to Group 5, indicating it's a recently approved or investigational agent with a unique mechanism of action. The procedure aims to deliver the therapeutic agent directly into the fatty layer beneath the skin for systemic or local effect.

This code is appropriate for procedures involving the subcutaneous administration of new and innovative drugs, biologics, or other therapeutic agents that have been specifically designated as "New Technology Therapeutic Substance, Group 5." This often includes early-stage clinical trials or the initial post-market use of groundbreaking therapies delivered via subcutaneous injection. It would be used when the substance is administered for therapeutic rather than diagnostic purposes.

• Verify that the substance administered is explicitly documented as a "New Technology Therapeutic Substance, Group 5" to ensure accurate code assignment.
• Confirm the approach was percutaneous and the target site was subcutaneous tissue; other approaches or sites would necessitate a different code.
• This code is for therapeutic intent; diagnostic injections of new technology substances would be coded differently.